Characteristics of Hospitalizations for Heart Failure with Preserved Ejection Fraction

American Journal of Medicine

Volumn 129, Issue 6, 2016, Pages 635.e15-635.e26

  Goyal, Parag ^a   Almarzooq, Zaid I ^a   Horn, Evelyn M ^a   Karas, Maria G ^a   Sobol, Irina ^a   Swaminathan, Rajesh V ^a   Feldman, Dmitriy N ^a   Minutello, Robert M ^a   Singh, Harsimran S ^a   Bergman, Geoffrey W ^a   Wong, S Chiu ^a   Kim, Luke K ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Epidemiology; Heart failure; Mortality

Indexed keywords

ACUTE HEART FAILURE; ADULT; AGED; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HEART EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; HYPERTENSION; ICD-9-CM; LENGTH OF STAY; LIVER DISEASE; LUNG CIRCULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; ACUTE DISEASE; ADOLESCENT; AGE DISTRIBUTION; CLASSIFICATION; COMORBIDITY; HEALTH INSURANCE; HEART FAILURE; HEART STROKE VOLUME; HOSPITAL DISCHARGE; OUTCOME ASSESSMENT; PHYSIOLOGY; REGRESSION ANALYSIS; SEX RATIO; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; COMORBIDITY; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; REGRESSION ANALYSIS; SEX DISTRIBUTION; STROKE VOLUME; UNITED STATES; YOUNG ADULT;

EID: 84969856701     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2016.02.007     Document Type: Article

References (45)

1. B.A. Steinberg, X. Zhao, P.A. Heidenreich, and et al. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes Circulation 126 2012 65 75
2. G.C. Fonarow, W.G. Stough, W.T. Abraham, and et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry J Am Coll Cardiol 50 2007 768 777
3. C.W. Yancy, M. Lopatin, L.W. Stevenson, T. De Marco, G.C. Fonarow ADHERE Scientific Advisory Committee and Investigators Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol 47 1 2006 76 84
4. D.S. Lee, P. Gona, R.S. Vasan, and et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute Circulation 119 2009 3070 3077
5. J.S. Gottdiener, R.L. McClelland, R. Marshall, and et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study Ann Intern Med 137 2002 631 639
6. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
7. R.B. Devereux, M.J. Roman, J.E. Liu, and et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study Am J Cardiol 86 2000 1090 1096
8. D.W. Kitzman, J.M. Gardin, J.S. Gottdiener, and et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study Am J Cardiol 87 2001 413 419
9. Y. Gerber, S.A. Weston, M.M. Redfield, and et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010 JAMA Intern Med 175 2015 996 1004
10. S.J. Shah, D.H. Katz, S. Selvaraj, and et al. Phenomapping for novel classification of heart failure with preserved ejection fraction Circulation 131 2015 269 279
11. Healthcare Cost and Utilization Project (HCUP). HCUP Nationwide Inpatient Sample (NIS) 2007-2009 Agency for Healthcare Research and Quality Rockville, MD Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp Accessed December 12, 2015
12. C.S. Lam, and S.D. Solomon The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%) Eur J Heart Fail 16 2014 1049 1055
13. A. Elixhauser, C. Steiner, D.R. Harris, and R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1998 8 27
14. US Census Bureau. Population estimates and demographic components of change by age, sex, race, & Hispanic origin for the United States, 2003. Available at: https://www.census.gov/popest/data/state/totals/2003/tables/NST-EST2003-08.pdf. Accessed December 12, 2015.
15. J. Chen, K. Dharmarajan, Y. Wang, and H.M. Krumholz National trends in heart failure hospital stay rates, 2001 to 2009 J Am Coll Cardiol 61 2013 1078 1088
16. D.D. Tresch, and M.F. McGough Heart failure with normal systolic function: a common disorder in older people J Am Geriatr Soc 43 1995 1035 1042
17. B. Upadhya, G.E. Taffet, C.P. Cheng, and D.W. Kitzman Heart failure with preserved ejection fraction in the elderly: scope of the problem J Mol Cell Cardiol 83 2015 73 87
18. R.J. Mentz, J.P. Kelly, T.G. von Lueder, and et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction J Am Coll Cardiol 64 2014 2281 2293
19. M.M. Redfield, H.H. Chen, B.A. Borlaug, and et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 2013 1268 1277
20. F. Edelmann, R. Wachter, A.G. Schmidt, and et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791
21. B. Ng, L.H. Connors, R. Davidoff, M. Skinner, and R.H. Falk Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis Arch Intern Med 165 2005 1425 1429
22. C.W. Yancy, W.T. Abraham, N.M. Albert, and et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry J Am Coll Cardiol 51 2008 1675 1684
23. N. Ilksoy, M. Hoffman, R.H. Moore, K. Easley, and T.A. Jacobson Comparison of African-American patients with systolic heart failure versus preserved ejection fraction Am J Cardiol 98 2006 806 808
24. K. Fiscella, and K. Holt Racial disparity in hypertension control: tallying the death toll Ann Fam Med 6 2008 497 502
25. R.P. Hertz, A.N. Unger, J.A. Cornell, and E. Saunders Racial disparities in hypertension prevalence, awareness, and management Arch Intern Med 165 2005 2098 2104
26. P.M. Okin, S.E. Kjeldsen, B. Dahlof, and R.B. Devereux Racial differences in incident heart failure during antihypertensive therapy Circ Cardiovasc Qual Outcomes 4 2011 157 164
27. J.R. Kizer, D.K. Arnett, J.N. Bella, and et al. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study Hypertension 43 2004 1182 1188
28. A.M. Chamberlain, J.L. St Sauver, Y. Gerber, and et al. Multimorbidity in heart failure: a community perspective Am J Med 128 2015 38 45
29. P.E. Carson, I.S. Anand, S. Win, and et al. The hospitalization burden and post-hospitalization mortality risk in heart failure with preserved ejection fraction: results from the I-PRESERVE trial (irbesartan in heart failure and preserved ejection fraction) JACC Heart Fail 3 2015 429 441
30. M.R. Zile, W.H. Gaasch, I.S. Anand, and et al. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial Circulation 121 2010 1393 1405
31. F. Edelmann, R. Stahrenberg, G. Gelbrich, and et al. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction Clin Res Cardiol 100 2011 755 764
32. W.J. Paulus, and C. Tschope A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation J Am Coll Cardiol 62 2013 263 271
33. B.M. Massie, P.E. Carson, J.J. McMurray, and et al. Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
34. J.B. Somaratne, C. Berry, J.J. McMurray, K.K. Poppe, R.N. Doughty, and G.A. Whalley The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis Eur J Heart Fail 11 2009 855 862
35. Meta-analysis Global Group in Chronic Heart Failure The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Eur Heart J 33 14 2012 1750 1757
36. C.S. Lam, V.L. Roger, R.J. Rodeheffer, B.A. Borlaug, F.T. Enders, and M.M. Redfield Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study J Am Coll Cardiol 53 2009 1119 1126
37. M. Guazzi Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives Circ Heart Fail 7 2014 367 377
38. S. Ather, W. Chan, B. Bozkurt, and et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 2012 998 1005
39. D.H. Smith, M.L. Thorp, J.H. Gurwitz, and et al. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: the Cardiovascular Research Network PRESERVE Study Circ Cardiovasc Qual Outcomes 6 2013 333 342
40. C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 128 2013 1810 1852
41. D. Huang, and J.W. Cheng Pharmacologic management of heart failure with preserved ejection fraction Ann Pharmacother 44 2010 1933 1945
42. H. Bueno, J.S. Ross, Y. Wang, and et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 JAMA 303 2010 2141 2147
43. S. Pant, N.J. Patel, A. Deshmukh, and et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011 J Am Coll Cardiol 65 2015 2070 2076
44. A.J. Greenspon, J.D. Patel, E. Lau, and et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures J Am Coll Cardiol 60 2012 1540 1545
45. M.A. Pfeffer, B. Claggett, S.F. Assmann, and et al. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial Circulation 131 2015 34 42